142 related articles for article (PubMed ID: 27540290)
1. A dual brain-targeting curcumin-loaded polymersomes ameliorated cognitive dysfunction in intrahippocampal amyloid-β1-42-injected mice.
Jia T; Sun Z; Lu Y; Gao J; Zou H; Xie F; Zhang G; Xu H; Sun D; Yu Y; Zhong Y
Int J Nanomedicine; 2016; 11():3765-75. PubMed ID: 27540290
[TBL] [Abstract][Full Text] [Related]
2. The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.
Yu Y; Jiang X; Gong S; Feng L; Zhong Y; Pang Z
Nanoscale; 2014 Mar; 6(6):3250-8. PubMed ID: 24503971
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
Kuo YC; Chou PR
J Pharm Sci; 2014 Aug; 103(8):2484-97. PubMed ID: 25041794
[TBL] [Abstract][Full Text] [Related]
5. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
7. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease.
Mathew A; Fukuda T; Nagaoka Y; Hasumura T; Morimoto H; Yoshida Y; Maekawa T; Venugopal K; Kumar DS
PLoS One; 2012; 7(3):e32616. PubMed ID: 22403681
[TBL] [Abstract][Full Text] [Related]
8. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Kundu P; Das M; Tripathy K; Sahoo SK
ACS Chem Neurosci; 2016 Dec; 7(12):1658-1670. PubMed ID: 27642670
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
12. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
13. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
14. Effects of Newly Synthesized Recombinant Human Amyloid-β Complexes and Poly-Amyloid-β Fibers on Cell Apoptosis and Cognitive Decline.
Park S; Huh JW; Eom T; Na N; Lee Y; Kim JS; Kim SU; Shim I; Lee SR; Kim E
J Microbiol Biotechnol; 2017 Nov; 27(11):2044-2051. PubMed ID: 28910862
[TBL] [Abstract][Full Text] [Related]
15. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept.
Papadia K; Markoutsa E; Mourtas S; Giannou AD; La Ferla B; Nicotra F; Salmona M; Klepetsanis P; Stathopoulos GT; Antimisiaris SG
Eur J Pharm Sci; 2017 Apr; 101():140-148. PubMed ID: 28193538
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 protection against Aβ1-42-induced hippocampal neuronal inflammation and apoptosis by TβR-I.
Fang XX; Sun GL; Zhou Y; Qiu YH; Peng YP
Neuroreport; 2018 Jan; 29(2):141-146. PubMed ID: 29200096
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular injection of beta-amyloid in mice is associated with long-term cognitive impairment in the modified hole-board test.
Schmid S; Jungwirth B; Gehlert V; Blobner M; Schneider G; Kratzer S; Kellermann K; Rammes G
Behav Brain Res; 2017 May; 324():15-20. PubMed ID: 28193522
[TBL] [Abstract][Full Text] [Related]
20. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
